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Postpartum hemorrhage (PPH) contributes
significantly to the maternal morbidity and mortality all
over the world. It can transform normal woman in labor
to a critically ill patient within minutes. Even in the
developed nation like USA the incidence of maternal
deaths due to PPH is as high as 13% (1), with rates as
high as 40% from other parts of the world (2). Worldwide
it is estimated that at least 150,000 women per year bleed
to death during or immediately after labor (3).
Conventionally PPH has been defined as blood loss of
more than 500ml following vaginal delivery and 1000 ml
following a caesarean section (4). Another definition labels
PPH as any blood loss which causes a 10% drop in
hematocrit (5) or which threatens the hemodynamic
stability of the patient and necessitates blood transfusion
(6). Blood loss during first 24 hours after delivery is known
as primary PPH (placental / extra-placental, depending
upon the site of bleed), whereas blood loss from after 24
hours up to six weeks is termed as late or secondary
PPH (3). Uterine atony is the major cause responsible
for primary PPH in around 70 - 90% cases. Trauma to
the genital tract in the form of tears, lacerations,
hematomas or uterine rupture account for rest of the
cases. Traditionally uterine atony has been managed by
bimanual compression and massage along with use of
Oxytocin either alone or in combination with ergometrine.
Prostaglandins like carboprost and more recently
misoprostol are also helpful in controlling atonic PPH.
When medical management fails to restore the tone of
uterus internal compression of the uterus can be applied
using traditional packing of the uterus by 8 -10m sterilized
gauze or by using a distended condom tied to the simple
catheter by silk thread. The condom is then inflated by
connecting the catheter to a drip set. This causes uterine
tamponade and arrests bleeding.
Intractable PPH despite compression needs surgical
intervention ideally conservative in the form of uterine
and ovarian arteries ligation, B-Lynch sutures and internal
iliac arteries ligation or Embolization and hysterectomy
as last resort.
 Material and Methods
A prospective study was done at the Government Lalla
Ded Hospital, (associated hospital of Government Medical
College Srinagar) over a period of one year. 26
consecutive patients who developed intractable PPH in
the hospital and did not respond to the conventional
medical management and in whom traumatic PPH was
ruled out were selected.
A sterile simple red-rubber catheter (14Fr) fitted with
a condom at its tip was introduced into the uterus. A tight
vaginal pack was then applied followed by introduction
of normal saline by an infusion-set into the condom via
catheter. Around 250 to 500ml was required to adequately
inflate the condom and arrest bleeding. Uterine
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contractility was maintained by Oxytocin drip for 24 hours.
Prophylactic antibiotics were administered intravenously
as long as the condom catheter was in situ. The condom
catheter was kept in situ for 24 - 72 hours depending on
the severity of initial blood loss. Bleeding did not resume
in any patient when the condom catheter was gently
deflated over 10 - 15 minutes.
Results
Patients were in the age group of 21 to 38 years with
a mean age of 28.8 years. Parity ranged from 1 to 4 with
median of 2. Of the 26 patients 23 (88.5%) were of
primary PPH and 3 (11.5%) of secondary PPH. Six
patients were in shock at the time of intervention. Majority
of cases 24(92.3%) had spontaneous vaginal delivery and
2 (7.7%) cases were following a caesarean section
(Table-1).
In 23 (88.5%) cases, condom catheter was introduced
within 6 hours while in 3 (11.5%) cases of secondary
PPH on day 2. In all but one (96.2%) cases the bleeding
stopped within 10 minutes of creation of tamponade. On
an average 342.8ml of normal saline was required to
create adequate tamponade to stop the bleeding. The
patients required 2 to 5 units of whole blood (median 3
units) apart from the crystalloids to achieve hemodynamic
stability. No patient went into irreversible shock and no
patient developed any signs of sepsis. Patients were
monitored in the hospital for one week. Of the 25 patients
(96.2%) with successful tamponade none required any
further intervention and did not develop any further
complication (Table-2). In one patient, who was Para 4,
having secondary PPH the bleeding continued over the
vaginal pack for 2 hours after creation of tamponade.
She was taken up for emergency hysterectomy as her
condition was not getting stabilized despite adequate
simultaneous resuscitation.
Discussion
PPH is one of the leading problems faced by the
obstetricians all over the world. Since the window of time
to save life is short in PPH, prophylactic measures are
very important. Prophylactic uterotonics reduce the risk
of PPH by about 60% (3). Patients with intractable
bleeding can quickly become hemodynamically unstable
and develop a cascade of complications which can lead
to the death of the patient. For these surgical hemostasis
is to be initiated sooner rather than later.  Options like
ligation of uterine or internal iliac arteries, though
successfully tried, require complex pelvic dissection and
may not be always feasible in all situations. Embolization
requires multidisciplinary approach and expensive
infrastructure and is not an option available in peripheral
hospitals. Conventionally, hysterectomy was the ultimate
cure which could be provided, however the pressures to
preserve fertility and avoid hysterectomy have led to the
evolution of several techniques in recent times (7).
B-Lynch technique (8) for control of PPH is also a good
option but again is an invasive method.  In contrast the
balloon tamponade is simpler and handy alternative for
arresting the bleeding. It is a well recognized therapy in
patients of intractable PPH especially due to atony,
coagulopathy and placenta accreta and most of the
patients with intractable PPH do respond to tamponade
by various balloon devices like Sengstaken-Blakemore
tube (9, 10), Foley catheter  (11) and the less expensive
'Bakri tube' (12) and condom catheter (13, 14). They are
used as a means to compress the uterine sinuses and
thereby arrest PPH. Tamponade has been historically
tried with packing of the uterine cavity with ribbon gauze.
A 20m long ribbon is tightly inserted inside the uterus
starting from the fundus, otherwise bleeding will continue
above the packing. This, however, fell into disrepute due
to fear of continued concealed bleeding and infection of
the uterine cavity. Other forms of tamponade like
Sengstaken-Blakemore tube and Foley catheter have
been successfully and effectively used. These are
expensive, complex and not always readily available.
Condom catheter, on the contrary, is a simple economical
and definitely effective alternative. It confirms naturally
to the contour of the uterine cavity, does not require any
complex packing and is easy to remove. It is not
associated with any infection as there is no direct intra-
uterine manipulation and does not require extensive
surgical expertise.
The use of condom was first described by authors
from India (13) and Bangladesh (14) almost
simultaneously, who demonstrated the potential life-saving
Total number of patients 
with intractable PPH  26 (23 primary + 3 secondary) 
Age group  21 – 38 yrs (Mean: 28.8 yrs) 
Parity  1 – 4 (Median: 2) 
Mode of delivery  24 vaginal + 2 LSCS 
Average Saline required for 
uterine tamponade in the 
patients 
342.8 ml 
 
Table 1.  Characteristics of Patients Included in the Study
Response rate  96.2% 
Failure rate  3.8% 
 
Table 2. Response Rate to Use of Condom Catheter in
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utility of their technique. Our experience with condom
catheter, as means to cause tamponade and control PPH,
has been excellent in saving both time and money with
positive results in more than 95% cases. This technique
can be important especially in many obstetric settings in
the developing world where uterotonics, safe blood,
anesthesia and experienced obstetricians / surgeons are
not readily available round the clock. Adoption of this
technique and dissemination of knowledge about this
option may save lives in many settings worldwide. As
the procedure is very simple and safe, even the trained
birth attendants can apply it before referring patients to a
higher centre.
Conclusion
Present study encourages  a simple, low cost and easily
available yet effective alternative to manage a dreaded
obstetric complication like PPH encountered frequently
in under developed and developing countries where
meager resources do not allow delivery of ideal care to
the grass-root level patients. Use of condom catheter
can effectively help in reducing both maternal morbidity
and mortality associated with PPH.
Average Saline required for 
patients 
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There was lack of any book which shows proper guidance to the students and provides knowledge of both animal experiments and clinical
experiments at the optimum level. Scientifically and logically speaking, now we have come across book entitled "Practical Manual of
Experimental and Clinical Pharmacology" published by the JayPee Brothers Pvt. Ltd. and written by Dr. Bikash Medhi and Ajay
Prakash PGIMER, Chandigarh, India is found to be more expressive, point specific, properly arranged and explanatory to provide
experimental (animal) and clinical experiments. This book will be beneficial for MBBS, MD (Pharmacology), DM (Pharmacology), PhD,
M.Pharm and B. pharm students. This book, by Medhi and Prakash explains the points about the practical pharmacology, including the
proper handling of animals, blood withdrawal and ethics with their regulatory bodies.  In vitro Bioassay is explained logically with the
several examples to make clear the every points.  More importantly, human bioassay and cytokine bioassay are an added point in the
book. Several other important topic like principles of commonly and sophisticated instruments used in pharmacology laboratory,
pyrogen test; involves conventional in vivo rabbit experiment and In vitro modern technique. Book also briefly explained, practical aspect
of cell line culture, preclinical to clinical drug dose calculation and Protocol & thesis writing for postgraduate student, Toxicity study.
Biostatistics in pharmacology and Biomedical waste disposal. Thereafter, book covers the daily use practical for undergraduates,
postgraduates and DM (Pharmacology) students. They have made a separate section as per systems for the in vivo animal experiments
and classified in vitro bioassays; explained beautifully with tables and figures to make the subject easy to understand.Then, clinical
pharmacology part which is found to be very useful for MD and DM (pharmacology) residents. Lastly, they have also touched the hot
topic like impact factor, computational pharmacology, pharmacokinetic and pharmacodynamic (PK/PD) modeling, evaluation of
pharmaceuticals product literature and analytical toxicology. Moreover, new concept in pharmacology like translational medicine,
reverse pharmacology and micro dosing is well explained. So, finally it is a meticulous book for the undergraduates and postgraduates of
medical and pharmacy students. DM (pharmacology) will be benefited as well with the explained clinical pharmacology practical.
Moreover, it gives an excellent outflow of pharmacology experiments to teacher as well.
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